BMS-247550 in Treating Patients With Advanced Pancreatic Cancer
This study has been completed.
Southwest Oncology Group
Information provided by:
National Cancer Institute (NCI)
First received: June 6, 2001
Last updated: June 20, 2013
Last verified: April 2003
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2006|
|Estimated Primary Completion Date:||No date given|
Whitehead RP, McCoy S, Rivkin SE, Gross HM, Conrad ME, Doolittle GC, Wolff RA, Goodwin JW, Dakhil SR, Abbruzzese JL. A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study. Invest New Drugs. 2006 Nov;24(6):515-20.